SHILPAMEDBSEShilpa Medicare LtdMinimalNeutral
Announced Thu, 28 May · 12:55 IST

Annual Secretarial Compliance Report for the financial year 2025-26

SHILPAMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.9%1-day move
₹493.00
prior close
₹494.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.2+1.4+1.4+0.6+0.9+5.2+4.5+7.5+9.4+15.4+12.2+16.6
Up moveDown movePending
AI summary

Shilpa Medicare Limited has filed its Annual Secretarial Compliance Report for FY 2025-26, issued by Practicing Company Secretary D.S. Rao. The report covers compliance with key SEBI regulations including LODR 2015, ICDR 2018, SAST 2011, PIT Regulations 2015, Depositories Act, and related SEBI guidelines. The PCS has confirmed full compliance across all 13 checkpoints covering secretarial standards, board policies, website disclosures, director disqualification, subsidiaries, document preservation, performance evaluation, related party transactions, material event disclosures, insider trading norms, and SEBI/exchange actions. No violations, deviations, or fines were reported for the review period (April 1, 2025 to March 31, 2026), and no pending observations from prior reports remain unresolved.

Likely market impact

Clean compliance report with NIL deviations and NIL penalties is a positive signal for investors, indicating strong adherence to SEBI regulatory requirements and sound corporate governance practices at Shilpa Medicare.